Tagged with Allergy

New CEO for ALK as Carsten Hellmann Steps Down

Denmark New CEO for ALK as Carsten Hellmann Steps Down

Denmark Danish allergy specialist ALK will have a new CEO in 2024, with current incumbent Carsten Hellmann set to step down after a seven-year spell in the hot seat. Hellmann, 59, will be replaced by the comparatively youthful 45-year-old Peter Halling at the end of the year, which ALK Board Chairman…

ALK CEO Carsten Hellman Talks Strategic Transformation & Allergy Market Trends

Denmark ALK CEO Carsten Hellman Talks Strategic Transformation & Allergy Market Trends

Denmark Speaking after the recent completion of a three-year strategic transformation plan, ALK President and CEO Carsten Hellmann outlines the progress made by the Danish allergy giant under his stewardship, including deeper penetration of the US market, shifting from injections to tablets, and driving digitalisation and efficiency. To put our…

Carsten Hellmann – President & CEO, ALK

Denmark Carsten Hellmann – President & CEO, ALK

Denmark Speaking after the recent completion of a three-year strategic transformation plan, ALK President and CEO Carsten Hellmann outlines the progress made by the Danish allergy giant under his stewardship, including deeper penetration of the US market, shifting from injections to tablets, and driving digitalisation and efficiency. Hellmann also outlines the…

Interview: Sean Connor – General Manager Benelux and UK/ROI, ALK, The Netherlands

Pharma Interview: Sean Connor – General Manager Benelux and UK/ROI, ALK, The Netherlands

Pharma Sean Connor, General Manager Benelux and UK/ROI for ALK, details the company’s strategy both in terms of products and therapeutic areas and provides us with his assessment of Netherlands regulatory environment and market access. You have been General Manager for the UK and ROI since 2013, and, in January 2015,…

Interview: Harry Flore – CEO, HAL Allergy, The Netherlands

Pharma Interview: Harry Flore – CEO, HAL Allergy, The Netherlands

Pharma A well-established player in the Allergy market, the Dutch company HAL Allergy recently expanded its activities with the addition of its HALIX Contract Manufacturing Outsourcing (CMO) arm. CEO Harry Flore highlights how the complete package and Good Manufacturing Practice (GMP) experience offered by HALIX, along with the company’s long-standing in-house…

HAL Allergy Group Interview with Harry Flore, CEO, HAL Allergy Group

HAL Allergy Group Our meetings frequently bring us here to the Leiden Bio Science Park, but more often than not, to meet with younger, up-and-coming companies. HAL Allergy, meanwhile, has a rich and proud history in the Netherlands dating back more than 50 years to its origins in Haarlem. What have been the…

Other Topics

India

M&A

European Biotech

Cell & Gene Therapy

R&D Section Page